OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
B-cell non-Hodgkin lymphomas
Elisabeth Silkenstedt, Gilles Salles, Elı́as Campo, et al.
The Lancet (2024) Vol. 403, Iss. 10438, pp. 1791-1807
Closed Access | Times Cited: 15
Elisabeth Silkenstedt, Gilles Salles, Elı́as Campo, et al.
The Lancet (2024) Vol. 403, Iss. 10438, pp. 1791-1807
Closed Access | Times Cited: 15
Showing 15 citing articles:
Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells
Yang Liu, Xiaoshuang Yuan, Xu Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Yang Liu, Xiaoshuang Yuan, Xu Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study
Klervi Leuraud, Dominique Laurier, Michael Gillies, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 10, pp. e761-e769
Closed Access | Times Cited: 5
Klervi Leuraud, Dominique Laurier, Michael Gillies, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 10, pp. e761-e769
Closed Access | Times Cited: 5
Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)
B. Fulbert, T. K. Chow Vincent, Justine Clarenne, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
B. Fulbert, T. K. Chow Vincent, Justine Clarenne, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
The role of non-malignant B cells in malignant hematologic diseases
Daquan Gao
Hematology (2025) Vol. 30, Iss. 1
Open Access
Daquan Gao
Hematology (2025) Vol. 30, Iss. 1
Open Access
Circulating tumor DNA in lymphoma: technologies and applications
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Prognosis prediction in non‐Hodgkin lymphoma by assessing lymphoid organs uptake patterns using baseline 18F ‐FDG PET /CT
Jie Ding, Xinwei Cheng, Haiyan Wang, et al.
International Journal of Cancer (2025)
Closed Access
Jie Ding, Xinwei Cheng, Haiyan Wang, et al.
International Journal of Cancer (2025)
Closed Access
[Rituximab combined with intensive immunochemotherapy for sporadic adult Burkitt lymphoma: efficacy and prognosis analyse].
Chenming Dong, H S Zou, Wei Zhang, et al.
PubMed (2025) Vol. 46, Iss. 2, pp. 134-139
Closed Access
Chenming Dong, H S Zou, Wei Zhang, et al.
PubMed (2025) Vol. 46, Iss. 2, pp. 134-139
Closed Access
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma
Chin‐Mu Hsu, Shih‐Yu Kao, Chia‐Hung Yen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Chin‐Mu Hsu, Shih‐Yu Kao, Chia‐Hung Yen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Leukemia and lymphoma mimicking periapical conditions resulting in endodontic treatment: a systematic review
Isis Samara de Melo Queiroga, Victor Zanetti Drumond, Lucas Guimarães Abreu, et al.
Journal of Endodontics (2024)
Closed Access | Times Cited: 1
Isis Samara de Melo Queiroga, Victor Zanetti Drumond, Lucas Guimarães Abreu, et al.
Journal of Endodontics (2024)
Closed Access | Times Cited: 1
Fungal infection in patients treated with Bruton's Tyrosine Kinase inhibitor, from epidemiology to clinical outcome: A systematic review
Charles Gibert, Marion Blaize, Arnaud Fekkar
Clinical Microbiology and Infection (2024)
Closed Access | Times Cited: 1
Charles Gibert, Marion Blaize, Arnaud Fekkar
Clinical Microbiology and Infection (2024)
Closed Access | Times Cited: 1
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma
Wei‐Wen Hu, Lanlan Zang, Xiaoxi Feng, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
Wei‐Wen Hu, Lanlan Zang, Xiaoxi Feng, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
Incidence trends of non-Hodgkin lymphoma in children in the United States from 2000 to 2020
Seyed Ehsan Mousavi, Kimia Motlagh Asghari, Armin Aslani, et al.
Clinical Epidemiology and Global Health (2024) Vol. 30, pp. 101850-101850
Open Access
Seyed Ehsan Mousavi, Kimia Motlagh Asghari, Armin Aslani, et al.
Clinical Epidemiology and Global Health (2024) Vol. 30, pp. 101850-101850
Open Access
Association of immunosuppressive CD45+CD33+CD14− CD10−HLA-DR−/low neutrophils with poor prognosis in patients with lymphoma and their expansion and activation through STAT3/arginase-1 pathway in vitro
Meng Xiao, Ji Zhou, Wanqiu Zhang, et al.
CytoJournal (2024) Vol. 21, pp. 69-69
Open Access
Meng Xiao, Ji Zhou, Wanqiu Zhang, et al.
CytoJournal (2024) Vol. 21, pp. 69-69
Open Access
Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma
Haotian Wang, Ying Zhang, Z Y Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Haotian Wang, Ying Zhang, Z Y Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
